Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


06.11.2017

3 Cancer Res
1 Clin Cancer Res
1 Curr Treat Options Oncol
1 Eur J Obstet Gynecol Reprod Biol
3 Gynecol Oncol
1 Int J Cancer
1 Int J Gynaecol Obstet
1 J Clin Oncol
1 Oncogene
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cancer Res

  1. GALL VA, Philips AV, Qiao N, Clise-Dwyer K, et al
    Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
    Cancer Res. 2017;77:5374-5383.
    PubMed     Text format     Abstract available

  2. YANG D, Sun B, Zhang X, Cheng D, et al
    Huwe1 sustains normal ovarian epithelial cell transformation and tumor growth through the histone H1.3-H19 cascade.
    Cancer Res. 2017 Jul 7. pii: canres.2597.2016.
    PubMed     Text format     Abstract available

  3. MARCHAN R, Buttner B, Lambert J, Edlund K, et al
    Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma.
    Cancer Res. 2017 Jun 26. pii: canres.2065.2016.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. LABIDI-GALY SI, Olivier T, Rodrigues M, Ferraioli D, et al
    Location of mutation in BRCA2 gene and survival in patients with ovarian cancer.
    Clin Cancer Res. 2017 Oct 30. pii: clincanres.2136.2017.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  5. AFGHAHI A, Kurian AW
    The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
    Curr Treat Options Oncol. 2017;18:27.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  6. VERMEULEN CKM, Tadesse W, Timmermans M, Kruitwagen RFPM, et al
    Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;219:100-105.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  7. YI Y, Tsai SH, Cheng JC, Wang EY, et al
    APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
    Gynecol Oncol. 2017 Oct 24. pii: S0090-8258(17)31419.
    PubMed     Text format     Abstract available

  8. SHALOWITZ DI, Nivasch E, Burger RA, Schapira MM, et al
    Are patients willing to travel for better ovarian cancer care?
    Gynecol Oncol. 2017 Oct 24. pii: S0090-8258(17)31421.
    PubMed     Text format     Abstract available

  9. CHAN JK, Kapp DS
    Clear Cell Ovarian Cancer: Optimum Management and Prognosis Remain Hazy.
    Gynecol Oncol. 2017;147:237-239.
    PubMed     Text format    


    Int J Cancer

  10. KIM J, Field A, Schultz KAP, Hill DA, et al
    The prevalence of DICER1 pathogenic variation in population databases.
    Int J Cancer. 2017;141:2030-2036.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  11. MAY T, Stewart JM, Bernardini MQ, Ferguson SE, et al
    The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer.
    Int J Gynaecol Obstet. 2017 Nov 2. doi: 10.1002/ijgo.12376.
    PubMed     Text format     Abstract available


    J Clin Oncol

  12. BERCHUCK A, Secord AA, Moss HA, Havrilesky LJ, et al
    Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?
    J Clin Oncol. 2017 Oct 26:JCO2017745752. doi: 10.1200/JCO.2017.74.5752.
    PubMed     Text format    


    Oncogene

  13. WANG J, Kho DH, Zhou JY, Davis RJ, et al
    MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance.
    Oncogene. 2017;36:5939-5947.
    PubMed     Text format     Abstract available


    PLoS One

  14. GENG X, Liu Y, Diersch S, Kotzsch M, et al
    Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.
    PLoS One. 2017;12:e0186847.
    PubMed     Text format     Abstract available

  15. QIN L, Li T, Liu Y
    High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer.
    PLoS One. 2017;12:e0187385.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: